“EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS” (2015) Mediterranean Journal of Hematology and Infectious Diseases, 7(1), p. e2015058. doi:10.4084/mjhid.2015.058.